# Pershing Square Inc.: financial statements, quarterly

PS · NYSE · CIK 2026053 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ps.md) · [Financials](/companies/ps/financials.md) · [Filings](/companies/ps/filings.md) · [Insiders](/companies/ps/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ps/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Revenue | $m | [52.3](/filings/0001193125-26-257665.md) | [53.2](/filings/0001193125-26-349628.md) | [57.5](/filings/0001193125-26-257665.md) | [54.2](/filings/0001193125-26-349628.md) |
| Operating income | $m | [10.4](/filings/0001193125-26-257665.md) | [20.1](/filings/0001193125-26-349628.md) | [5.1](/filings/0001193125-26-257665.md) | [(90.1)](/filings/0001193125-26-349628.md) |
| Interest expense | $m | [0.6](/filings/0001193125-26-257665.md) | [0.6](/filings/0001193125-26-349628.md) | [0.5](/filings/0001193125-26-257665.md) | [2.5](/filings/0001193125-26-349628.md) |
| Income tax | $m | [1.8](/filings/0001193125-26-257665.md) | [1.9](/filings/0001193125-26-349628.md) | [0.9](/filings/0001193125-26-257665.md) | [(9.3)](/filings/0001193125-26-349628.md) |
| Net income | $m | [19.7](/filings/0001193125-26-257665.md) | [23.7](/filings/0001193125-26-349628.md) | [(148)](/filings/0001193125-26-257665.md) | [(42.7)](/filings/0001193125-26-349628.md) |
| Diluted EPS | $ per share | not reported | [0.06](/filings/0001193125-26-349628.md) | not reported | [(0.11)](/filings/0001193125-26-349628.md) |
| Basic EPS | $ per share | not reported | [0.06](/filings/0001193125-26-349628.md) | not reported | [(0.11)](/filings/0001193125-26-349628.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [941](/filings/0001193125-26-257665.md) | [47.6](/filings/0001193125-26-349628.md) | [55.4](/filings/0001193125-26-349628.md) | [46.8](/filings/0001193125-26-257665.md) | [8.9](/filings/0001193125-26-349628.md) |
| Total assets | $m | not reported | not reported | [1,701](/filings/0001193125-26-349628.md) | [990](/filings/0001193125-26-257665.md) | [1,813](/filings/0001193125-26-349628.md) |
| Total liabilities | $m | not reported | not reported | [622](/filings/0001193125-26-349628.md) | [106](/filings/0001193125-26-257665.md) | [403](/filings/0001193125-26-349628.md) |
| Long-term debt | $m | not reported | not reported | not reported | [34.8](/filings/0001193125-26-257665.md) | [232](/filings/0001193125-26-349628.md) |
| Shareholders' equity | $m | not reported | not reported | not reported | not reported | [1,409](/filings/0001193125-26-349628.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | period not labelled (2025-03-31) | period not labelled (2025-06-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [65.1](/filings/0001193125-26-257665.md) | [(258) d](/filings/0001193125-26-349628.md) | [87.9](/filings/0001193125-26-257665.md) | [25.4 d](/filings/0001193125-26-349628.md) |
| Dividends paid | $m | [88.5](/filings/0001193125-26-257665.md) | [27.1 d](/filings/0001193125-26-349628.md) | [90.6](/filings/0001193125-26-257665.md) | [27.5 d](/filings/0001193125-26-349628.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [400](/filings/0001193125-26-349628.md) | [400](/filings/0001193125-26-349628.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 400,000,000 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001193125-26-349628.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. No prices; not investment advice.